📖
Cardiovascular adverse events of tocilizumab and baricitinib in COVID-19 and rheumatoid arthritis: A real-world disproportionality and machine learning analysis.
Moon J, Lee C, Lee S, Kim M, Wen X, Branda F, Oh J, Son Y, Lee K, Choi T, Yon DK

Cardiovascular adverse events of tocilizumab and baricitinib in COVID-19 and rheumatoid arthritis: A real-world disproportionality and machine learning analysis.

Medicine & Health Verification Pending

Overview & Synopsis

Open access biomedical research article published in Medicine (Baltimore).

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Cardiovascular adverse events of tocilizumab and baricitinib in COVID-19 and rheumatoid arthritis: A real-world disproportionality and machine learning analysis.
Author / Organization Moon J, Lee C, Lee S, Kim M, Wen X, Branda F, Oh J, Son Y, Lee K, Choi T, Yon DK
Subject & Discipline Medicine (Baltimore)
Categories Medicine & Health
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-153757
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »